Tom Daniel

Tom Daniel has served as a member of our Board of Directors since October 2016. Dr. Daniel is currently Chairman of Locanabio, Inc., and is a director at Gossamer Bio, Inc. He was recently a venture partner at ARCH Venture Partners from October 2016 through June 2021, and served as Chairman of Research at Celgene Corporation, and as President of Research and Early Development from December 2006 until February 2012, and as Executive Vice President and President of Research and Early Development until December 2015. Dr. Daniel is a Trustee of Reed College, serves on the Board of the Alliance for Lupus Research and advises privately-held biotechnology companies including Brii Biosciences Limited, Epirium Bio, Inc. and Inception Therapeutics. Dr. Daniel serves as Director and Chairman of the Board of Overseers of The Scripps Research Institute and on the Biomedical Science Advisory Board of Vanderbilt University Medical Center. A nephrologist and former academic investigator, Tom was previously C.M. Hakim Professor of Medicine and Cell Biology at Vanderbilt. He earned his medical degree from the University of Texas Southwestern (UTSW), trained in molecular genetics at UTSW, and completed a medical residency at Massachusetts General Hospital.